A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Part of paid clinical trials in Gilbert, Arizona.
- Sponsor
- Janssen Research & Development, LLC
- Study ID
- NCT05552222
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Teclistamab — DRUGTeclistamab will be administered as SC injection.
- Daratumumab — DRUGDaratumumab will be administered as SC injection.
- Lenalidomide — DRUGLenalidomide will be administered orally.
- Dexamethasone — DRUGDexamethasone will be administered either orally or intravenously (IV).
- Talquetamab — DRUGTalquetamab will be administered as SC injection.
Study Details
The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) versus daratumumab, lenalidomide, dexamethasone (DRd).
Key Dates
- Start date
- Oct 25, 2022
- Status verified
- Jun 2026
- Primary completion
- Apr 30, 2031
- Completion
- Oct 28, 2033
Study Design
- Enrollment
- 1,590 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Teclistamab, Daratumumab SC, and Lenalidomide (Tec-DR)Participants will receive teclistamab as subcutaneous (SC) injection in combination with daratumumab and lenalidomide.
- Experimental: Talquetamab, Daratumumab SC, and Lenalidomide (Tal-DR)Participants will receive talquetamab as SC injection in combination with daratumumab and lenalidomide.
- Active Comparator: Daratumumab SC, Lenalidomide, and Dexamethasone (DRd)Participants will receive daratumumab as SC injection with lenalidomide and dexamethasone.
Primary Outcome Measure
Progression Free Survival (PFS) [ Time Frame: From randomization to the date of disease progression or death (Up to 09 years) ]
Central Contacts
- Study Contact844-434-4210
Locations (67)
Find similar trials in Gilbert, AZ
By condition
By specialty
Related Studies
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Collection of Tissue Samples for Cancer ResearchRecruiting · National Cancer Institute (NCI) · Sacramento, California
- Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample ResourceRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Tissue Collection for Studies of Lymph CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland